ITCC-052 CARFILZOMIB
Phase 1b/2 Study of Carfilzomib in combination with Dexamethasone, Mitoxantrone, PEG-asparaginase, and Vincristine (R3 Induction Backbone) in pediatric subjects with relapsed or refractory Acute Lymphoblastic Leukemia
Promotor Name : Amgen
Investigator Name : A. BARUCHEL
Trial registered on clinicaltrials.gov: NCT02303821